| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma. | Oncology | 2016 | 0.75 |
| 2 | First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients. | JCI Insight | 2017 | 0.75 |